Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

2.

Characterization of an Epstein-Barr virus-related gammaherpesvirus from common marmoset (Callithrix jacchus).

Jenson HB, Ench Y, Zhang Y, Gao SJ, Arrand JR, Mackett M.

J Gen Virol. 2002 Jul;83(Pt 7):1621-33.

PMID:
12075080
3.

High level expression and purification of the Epstein-Barr virus encoded cytokine viral interleukin 10: efficient removal of endotoxin.

Salek-Ardakani S, Stuart AD, Arrand JE, Lyons S, Arrand JR, Mackett M.

Cytokine. 2002 Jan 7;17(1):1-13.

PMID:
11886166
4.

Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.

Nicholls J, Kremmer E, Meseda CA, Mackett M, Hahn P, Gulley ML, Brink A, Swinnen LJ, Greenspan J, De Souza Y, Grässer F, Sham J, Ng MH, Arrand JR.

J Med Virol. 2001 Sep;65(1):105-13.

PMID:
11505451
5.

Transferrin receptor-mediated gene transfer to the corneal endothelium.

Tan PH, King WJ, Chen D, Awad HM, Mackett M, Lechler RI, Larkin DF, George AJ.

Transplantation. 2001 Feb 27;71(4):552-60.

PMID:
11258435
6.

Vaccinia expression of Mycobacterium tuberculosis-secreted proteins: tissue plasminogen activator signal sequence enhances expression and immunogenicity of M. tuberculosis Ag85.

Malin AS, Huygen K, Content J, Mackett M, Brandt L, Andersen P, Smith SM, Dockrell HM.

Microbes Infect. 2000 Nov;2(14):1677-85.

PMID:
11137041
7.

Heparin and heparan sulfate bind interleukin-10 and modulate its activity.

Salek-Ardakani S, Arrand JR, Shaw D, Mackett M.

Blood. 2000 Sep 1;96(5):1879-88.

8.

Herpesvirus papio encodes a functional homologue of the Epstein-Barr virus apoptosis suppressor, BHRF1.

Meseda CA, Arrand JR, Mackett M.

J Gen Virol. 2000 Jul;81(Pt 7):1801-5.

PMID:
10859386
9.

Epidemiology of herpesvirus papio infection in a large captive baboon colony: similarities to Epstein-Barr virus infection in humans.

Jenson HB, Ench Y, Gao SJ, Rice K, Carey D, Kennedy RC, Arrand JR, Mackett M.

J Infect Dis. 2000 Apr;181(4):1462-6. Epub 2000 Apr 13.

PMID:
10762578
10.

Recombinant vaccinia viruses protect against Clostridium perfringens alpha-toxin.

Bennett AM, Lescott T, Phillpotts RJ, Mackett M, Titball RW.

Viral Immunol. 1999;12(2):97-105.

PMID:
10413356
11.

Protection against herpes B virus infection in rabbits with a recombinant vaccinia virus expressing glycoprotein D.

Bennett AM, Slomka MJ, Brown DW, Lloyd G, Mackett M.

J Med Virol. 1999 Jan;57(1):47-56.

PMID:
9890421
12.

Immunization of common marmosets with Epstein-Barr virus (EBV) envelope glycoprotein gp340: effect on viral shedding following EBV challenge.

Cox C, Naylor BA, Mackett M, Arrand JR, Griffin BE, Wedderburn N.

J Med Virol. 1998 Aug;55(4):255-61.

PMID:
9661832
13.

BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates.

Khanim F, Dawson C, Meseda CA, Dawson J, Mackett M, Young LS.

J Gen Virol. 1997 Nov;78 ( Pt 11):2987-99.

PMID:
9367386
14.

The processing, transport and heterologous expression of Epstein-Barr virus gp110.

Papworth MA, Van Dijk AA, Benyon GR, Allen TD, Arrand JR, Mackett M.

J Gen Virol. 1997 Sep;78 ( Pt 9):2179-89.

PMID:
9292005
15.

Genetic content and preliminary transcriptional analysis of a representative region of murine gammaherpesvirus 68.

Mackett M, Stewart JP, de V Pepper S, Chee M, Efstathiou S, Nash AA, Arrand JR.

J Gen Virol. 1997 Jun;78 ( Pt 6):1425-33.

PMID:
9191940
16.

Preventive effect of IgG from EBV-seropositive donors on the development of human lympho-proliferative disease in SCID mice.

Abedi MR, Linde A, Christensson B, Mackett M, Hammarström L, Smith CI.

Int J Cancer. 1997 May 16;71(4):624-9.

17.

Immunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBV.

Mackett M, Cox C, Pepper SD, Lees JF, Naylor BA, Wedderburn N, Arrand JR.

J Med Virol. 1996 Nov;50(3):263-71.

PMID:
8923292
18.

Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.

Flynn JN, Keating P, Hosie MJ, Mackett M, Stephens EB, Beatty JA, Neil JC, Jarrett O.

J Immunol. 1996 Oct 15;157(8):3658-65.

PMID:
8871667
19.

Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein.

Stewart JP, Janjua NJ, Pepper SD, Bennion G, Mackett M, Allen T, Nash AA, Arrand JR.

J Virol. 1996 Jun;70(6):3528-35.

21.

The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.

Stuart AD, Stewart JP, Arrand JR, Mackett M.

Oncogene. 1995 Nov 2;11(9):1711-9.

PMID:
7478598
22.
23.
24.

Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide.

Flynn JN, Cannon CA, Beatty JA, Mackett M, Rigby MA, Neil JC, Jarrett C.

J Virol. 1994 Sep;68(9):5835-44.

25.

The Epstein-Barr virus candidate vaccine antigen gp340/220 is highly conserved between virus types A and B.

Lees JF, Arrand JE, Pepper SD, Stewart JP, Mackett M, Arrand JR.

Virology. 1993 Aug;195(2):578-86.

PMID:
8393237
26.
27.

Expression of human papillomavirus type 16 E7 protein by recombinant baculovirus and use for the detection of E7 antibodies in sera from cervical carcinoma patients.

Stacey SN, Ghosh A, Bartholomew JS, Tindle RW, Stern PL, Mackett M, Arrand JR.

J Med Virol. 1993 May;40(1):14-21.

PMID:
7685808
28.
29.

Expression of human papillomavirus type 16 E6 protein by recombinant baculovirus and use for detection of anti-E6 antibodies in human sera.

Stacey SN, Bartholomew JS, Ghosh A, Stern PL, Mackett M, Arrand JR.

J Gen Virol. 1992 Sep;73 ( Pt 9):2337-45.

PMID:
1328490
30.
31.

Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. 1984.

Wiktor TJ, MacFarlan RI, Reagan KJ, Dietzschold B, Curtis PJ, Wunner WH, Kieny MP, Lathe R, Lecocq JP, Mackett M, et al.

Biotechnology. 1992;24:508-12. No abstract available.

PMID:
1422063
32.

Vaccinia virus: a selectable eukaryotic cloning and expression vector. 1982.

Mackett M, Smith GL, Moss B.

Biotechnology. 1992;24:495-9. No abstract available.

PMID:
1422060
33.

Purification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus virus expression vector system.

Madej M, Conway MJ, Morgan AJ, Sweet J, Wallace L, Qualtiere LF, Arrand JR, Mackett M.

Vaccine. 1992;10(11):777-82.

PMID:
1332270
34.

Diagnosis of nasopharyngeal carcinoma by means of recombinant Epstein-Barr virus proteins.

Littler E, Baylis SA, Zeng Y, Conway MJ, Mackett M, Arrand JR.

Lancet. 1991 Mar 23;337(8743):685-9.

PMID:
1672175
35.

The live vector approach-viruses.

Mackett M.

World J Microbiol Biotechnol. 1991 Mar;7(2):137-49. doi: 10.1007/BF00328983.

PMID:
24424925
36.

Manipulation of vaccinia virus vectors.

Mackett M.

Methods Mol Biol. 1991;7:129-46. doi: 10.1385/0-89603-178-0:129.

PMID:
21416353
37.

Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route.

Williamson JD, Reith RW, Jeffrey LJ, Arrand JR, Mackett M.

J Gen Virol. 1990 Nov;71 ( Pt 11):2761-7. Erratum in: J Gen Virol 1991 Feb;72 (Pt 2):474.

PMID:
2254756
38.

Characterization and expression of a glycoprotein encoded by the Epstein-Barr virus BamHI I fragment.

Mackett M, Conway MJ, Arrand JR, Haddad RS, Hutt-Fletcher LM.

J Virol. 1990 Jun;64(6):2545-52.

39.

Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.

Murray RJ, Kurilla MG, Griffin HM, Brooks JM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E, et al.

Proc Natl Acad Sci U S A. 1990 Apr;87(8):2906-10.

40.

Vectors with multiple insertion sites for expression of cloned genes by T7 RNA polymerase: expression of a peptide from EBV thymidine kinase (TK).

Mackett M, Littler E, Michael R, Gartland M, Arrand JR.

Nucleic Acids Res. 1990 Feb 25;18(4):1082. No abstract available.

41.

Enhanced expression of the Epstein-Barr virus latent membrane protein by a recombinant vaccinia virus.

Stewart JP, Hampson IN, Heinrich HW, Mackett M, Arrand JR.

J Gen Virol. 1989 May;70 ( Pt 5):1231-7.

PMID:
2543776
42.
43.
44.

Recombinant vaccinia virus expressing Epstein-Barr virus glycoprotein gp340 protects cottontop tamarins against EB virus-induced malignant lymphomas.

Morgan AJ, Mackett M, Finerty S, Arrand JR, Scullion FT, Epstein MA.

J Med Virol. 1988 Jun;25(2):189-95.

PMID:
2839612
45.

Recombinant live virus vaccines.

Mackett M.

Immunol Lett. 1987 Dec;16(3-4):243-8. Review.

PMID:
3327813
46.

Toxoplasmosis in two renal transplant recipients from a single donor.

Mason JC, Ordelheide KS, Grames GM, Thrasher TV, Harris RD, Bui RH, Mackett MC.

Transplantation. 1987 Oct;44(4):588-91. No abstract available.

PMID:
3313851
47.

Vaccinia virus recombinants: potential vaccines.

Mackett M.

Acta Trop Suppl. 1987 Jun;12:94-7. Review. No abstract available.

PMID:
3307346
48.

Vaccinia virus expression vectors.

Mackett M, Smith GL.

J Gen Virol. 1986 Oct;67 ( Pt 10):2067-82. Review. No abstract available.

PMID:
3531399
49.

Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes.

Yewdell JW, Bennink JR, Mackett M, Lefrancois L, Lyles DS, Moss B.

J Exp Med. 1986 Jun 1;163(6):1529-38.

Supplemental Content

Loading ...
Support Center